retatrutide 10mg vial & 20mg Research Peptide Retatrutide - 10mg — Drakon

They activate GLP-1 receptors in the pancreas, the gut, and critically, the brain

Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, Tan MH, Khan MA, Perez AT, Jacober SJ

Frontiers in endocrinology 12: 645563

As expected, we found that MB07811 treatment not only reduced the body weight, fat weight, liver weight without changing food intake, but also lowered the blood glucose levels in HFD-fed mice (Fig

Guidelines currently recommend organ-specific management of obesity-related complications

While its not yet approved in Ireland, Retatrutide is currently in late-stage clinical trials, with availability expected from 2026 onwards